Transient Perforating Folliculitis Induced by Sorafenib

The document discussed a case of transient perforating folliculitis induced by sorafenib, a medication used in cancer treatment. Sorafenib was known to cause various dermatological side effects, and this case highlighted its potential to induce perforating folliculitis, a rare skin condition characterized by the transepidermal elimination of altered dermal material. The condition was observed to be transient, resolving after the discontinuation of sorafenib. This case contributed to the understanding of the dermatological side effects associated with sorafenib and emphasized the importance of recognizing and managing such adverse effects in patients undergoing treatment with this drug.